newsfilter
← Latest News
GlobeNewswire·

Cerevel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates

Emraclidine Phase 1 healthy elderly volunteer trial enrollment underway to support development in Alzheimer's disease psychosis Emraclidine Phase 2 schizophrenia data readout remains on track for 1H 2024 Clinical trial